People with Genetic Risk Factors: APOE4, BRCA, Lp(a) & Longevity
Your genes are not your destiny — but they are your terrain. If you carry APOE4, BRCA1/2, elevated Lp(a), or other genetic risk variants, the standard longevity protocol isn't enough. You need a precision approach that addresses your specific biological vulnerabilities. This guide covers what changes when genetics stack the deck against you.
Testing & Screening
Some genetic risks call for earlier or extra screening, set out in specific guidelines rather than by testing everything.
Exercise
Exercise and other healthy habits help whatever your genes.
Nutrition
Genetic risk factors often require more aggressive dietary interventions than standard longevity recommendations.
Supplements
Genetic risk-specific supplementation should be guided by your specific variants and monitored with appropriate biomarkers.
Risk Management
Living with genetic risk requires a mindset shift: from reactive healthcare to proactive risk engineering.
Frequently Asked Questions
References & Sources
- 1Frosst P, et al. "A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase." Nat Genet. 1995;10(1):111-3. PubMed · DOI
- 2Ashfield-Watt PA, et al. "Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial." Am J Clin Nutr. 2002;76(1):180-6. PubMed · DOI
- 3Lamers Y, et al. "Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women." Am J Clin Nutr. 2004;79(3):473-8. PubMed · DOI
- 4Barry MJ, et al. "Folic Acid Supplementation to Prevent Neural Tube Defects: US Preventive Services Task Force Reaffirmation Recommendation Statement." JAMA. 2023;330(5):454-459. PubMed · DOI
- 5Kronenberg F, et al. "Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement." Eur Heart J. 2022;43(39):3925-3946. PubMed · DOI
- 6Owens DK, et al. "Screening for Cognitive Impairment in Older Adults: US Preventive Services Task Force Recommendation Statement." JAMA. 2020;323(8):757-763. PubMed · DOI
- 7Landray MJ, et al. "Effects of extended-release niacin with laropiprant in high-risk patients." N Engl J Med. 2014;371(3):203-12. PubMed · DOI
- 8Lourida I, et al. "Association of Lifestyle and Genetic Risk With Incidence of Dementia." JAMA. 2019;322(5):430-437. PubMed · DOI